Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial from Truway Health, Inc. investigates regenerative medicine and stem cell-based interventions for inner ear trauma, tinnitus, and sensori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Truway Health, Inc. | Conditions: Sensorineural Hearing Loss, Tinnitus | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION